Physician profile
Ross E Bunch
NPI 1598728925
$6,466.50
in general payments reported to CMS, 2019-2025
26 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,910 · 2020: $226 · 2021: $697 · 2022: $605 · 2023: $196 · 2024: $634 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $722 · Debt Forgiveness: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $721.52 |
| Debt Forgiveness | $306.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,500.65 | 2019-2022 | |
| Stryker Corporation | $827.94 | 2019 | |
| Mentor Worldwide LLC | $732.45 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Galderma Laboratories, L.P. | $682.78 | 2019-2025 | |
| Merz North America, INC. | $368.13 | 2019 | |
| Johnson & Johnson Health Care Systems INC. | $306.00 | 2024 | |
| Tela Bio, INC. | $220.77 | 2020-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Lumenis Be INC | $178.46 | 2024 | Optilight |
| Integra Lifesciences Corporation | $121.68 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Sientra, INC. | $107.31 | 2020-2022 | |
| Conmed Corporation | $75.31 | 2019-2025 | Visiclear, Conmed Pads and Pencils |
| Kowa Pharmaceuticals America, INC. | $48.59 | 2023 | Seglentis |
| Ethicon US, LLC | $40.60 | 2020-2021 | |
| Abbvie INC. | $27.50 | 2025 | |
| Tei Biosciences INC | $26.73 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apyx Medical Corporation | $26.45 | 2019-2020 | |
| Motiva USA, LLC | $24.67 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $21.44 | 2025 | |
| Organogenesis INC. | $20.83 | 2022 | |
| Davol INC. | $19.75 | 2021 | |
| Baudax Bio INC. | $19.60 | 2021 | |
| Heron Therapeutics, INC. | $18.84 | 2025 | Zynrelef |
| Baxter Healthcare | $18.65 | 2022 | |
| Depuy Synthes Sales INC. | $16.14 | 2022 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $15.23 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ross Bunch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.